Dementia is a clinical syndrome caused by brain pathology, with core features including progressive decline in memory, language, comprehension, judgment, behavior, and daily living abilities, often accompanied by changes in personality and emotions. With an aging population, dementia has become a major global public health challenge. Clinical diagnosis does not rely on a single test but requires a comprehensive evaluation combining medical history, clinical observation, cognitive function testing, neuroimaging, and laboratory examinations.
I. Medical History Collection and Clinical Observation
Medical History Collection
Medical history is the foundation of diagnosis. Physicians inquire about the onset time of symptoms, progression speed, associated psychiatric or physical illnesses, and family history. Because patients often lack insight, supplementary information from family members or caregivers is crucial. Medical history collection goes beyond simple questioning and includes detailed understanding of past lifestyle habits, such as chronic illnesses, history of stroke, substance abuse, or long-term medication use. Educational level and occupational background must also be considered, as these factors affect “cognitive reserve” and influence disease presentation.
Clinical Observation
Physicians observe language expression, emotional responses, behavioral patterns, and daily living abilities. Clinical observation provides direct clues, such as whether the patient can follow simple instructions, shows disorientation, or exhibits personality changes. During observation, physicians pay attention to whether the patient can maintain attention, sustain logical conversation, and whether emotional instability or social withdrawal is present. These details often reveal early signs of cognitive impairment.
II. Cognitive Function Testing
Cognitive function testing is a core tool in dementia diagnosis, used to quantify cognitive abilities. Common tests include:
- MoCA (Montreal Cognitive Assessment): Suitable for early detection of cognitive impairment. MoCA covers multiple domains including attention, executive function, memory, language, visuospatial ability, and orientation. It is more sensitive than the Mini-Mental State Examination (MMSE), making it more effective in identifying mild cognitive impairment.
In clinical practice, physicians interpret test scores to determine whether significant cognitive decline exists. If scores fall below standard thresholds, results must be integrated with medical history and other examinations. Cognitive testing is not only diagnostic but also essential for monitoring disease progression, helping physicians evaluate the rate of decline.
III. Functional and Behavioral Testing
Beyond cognitive testing, physicians assess daily living abilities. These tests reflect the real-life impact of dementia and are critical for diagnosis:
- Activities of Daily Living (ADL): Basic self-care skills such as dressing, toileting, eating, and bathing. Difficulties in these areas usually indicate moderate to severe stages of disease.
- Instrumental Activities of Daily Living (IADL): More complex skills such as managing finances, shopping, cooking, using the telephone, and transportation. These functions require higher cognitive support and are often impaired in early stages.
Physicians evaluate functional status by asking whether patients can independently handle money, remember shopping lists, or safely use public transport. These details help determine disease severity and guide care planning.
IV. Auxiliary Examinations
Neuroimaging
- MRI or CT: Used to exclude brain tumors, hydrocephalus, or stroke, and to observe brain atrophy. MRI provides clearer structural imaging, revealing hippocampal atrophy typical of Alzheimer’s disease.
- PET Scan: Detects β-amyloid or tau protein deposition, serving as important biomarkers for Alzheimer’s disease. These scans can reveal pathology before clinical symptoms appear, aiding early diagnosis.
Cerebrospinal Fluid (CSF) Testing
Measures tau protein and β-amyloid levels. Decreased β-amyloid and elevated phosphorylated tau usually indicate ongoing Alzheimer’s pathology.
Blood Tests
Primarily used to exclude reversible causes such as hypothyroidism, vitamin B12 deficiency, infections, or metabolic disorders. Treating these conditions may restore cognitive function.
Genetic Testing
Applied to familial early-onset Alzheimer’s disease (e.g., PSEN1, PSEN2, APP mutations). Genetic testing provides definitive diagnosis but is limited to patients with strong family history due to ethical and psychological considerations.
V. Clinical and Public Health Significance
Early Diagnosis
Facilitates timely intervention, slows disease progression, and enables care planning. Patients diagnosed at mild stages can benefit from pharmacological and non-pharmacological treatments, as well as lifestyle adjustments to preserve function.
Excluding Reversible Causes
Not all dementia is irreversible. Depression, thyroid disorders, vitamin deficiencies, and medication side effects can cause cognitive decline. Identifying and treating these factors may restore normal cognition.
Interdisciplinary Collaboration
Diagnosis and care require participation from psychiatry, neurology, dietitians, psychotherapy, and community resources. Collaborative care provides integrated support across medical, psychological, nutritional, and social domains, ensuring comprehensive and continuous patient care.
Public Health Impact
Early detection and diagnosis reduce family and societal burden, improving patient quality of life. With aging populations, dementia cases are rising; systematic diagnostic processes and early intervention can significantly lower social costs.
Conclusion
Dementia diagnosis requires a multi-layered, comprehensive evaluation rather than reliance on a single test. Physicians must integrate medical history, clinical observation, cognitive testing, neuroimaging, and laboratory examinations, following international standards to confirm impairment across multiple cognitive domains affecting daily life. Early diagnosis not only slows disease progression but also excludes reversible causes, providing patients and families with better care and support.
In aging societies, dementia poses increasingly severe challenges. Only through professional diagnosis, interdisciplinary collaboration, and community education can patient and family quality of life be truly enhanced, caregiving burdens reduced, and societal understanding and acceptance of dementia promoted.
